Will the Top at 2.65 USD be tested or will it go down to 2,0 USD (Volume Point of Control) first? The most analysts aim for 7.5 USD for end of this year. With the cancer therapies in their portfolio it will be there a lot earlier I think.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.